VALIDATION OF ANCA-ASSOCIATED VASCULITIS AS THE CAUSE OF END-STAGE RENAL DISEASE IN THE UNITED STATES RENAL DATA SYSTEM

被引：0
|
作者：
Cook, C. [1 ]
Choi, H. [1 ,2 ]
Wallace, Z. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.2138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1428
引用
收藏
页码：997 / 998
页数：2
相关论文
共 50 条
  • [1] End-stage renal disease in ANCA-associated vasculitis
    Moiseev, Sergey
    Novikov, Pavel
    Jayne, David
    Mukhin, Nikolay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (02) : 248 - 253
  • [2] END-STAGE RENAL DISEASE RELATED FACTORS IN ANCA-ASSOCIATED VASCULITIS
    Ferrer Garcia, Guillermo
    Moral Berrio, Esperanza
    Castro Fernandez, Maria Paz
    Piccone Saponara, Luis Guillermo
    Carreno Parrilla, Agustin
    Martinez Calero, Alberto
    Arambarri Segura, Minerva
    Sidel Tambo, Diego
    Sanchez Escudero, Patricia
    Vozmediano Poyatos, Carmen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [3] ANCA-ASSOCIATED VASCULITIS IN END STAGE RENAL DISEASE
    Wang, Song
    Wang, Yue
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1556 - 1556
  • [4] Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis
    Haubitz, M
    de Groot, K
    CLINICAL NEPHROLOGY, 2002, 57 (06) : 421 - 424
  • [5] Performance of Berden's Classification and ANCA Renal Risk Score for the Prediction of End-Stage Renal Disease in ANCA-associated Vasculitis
    Gercik, Onay
    Bilgin, Emre
    Solmaz, Dilek
    Cakalagaoglu, Fulya
    Saglam, Arzu
    Aybi, Ozge
    Kardas, Riza
    Soypacaci, Zeki
    Kabadayi, Gokhan
    Yildirim, Tolga
    Aysin, Idil Kurut
    Karadag, Omer
    Akar, Servet
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System
    Cook, Claire E.
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John H.
    Choi, Hyon K.
    Wallace, Zachary S.
    ACR OPEN RHEUMATOLOGY, 2022, 4 (01) : 8 - 12
  • [7] Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis
    Gercik, Onay
    Bilgin, Emre
    Solmaz, Dilek
    Cakalagaoglu, Fulya
    Saglam, Arzu
    Aybi, Ozge
    Kardas, Riza Can
    Soypacaci, Zeki
    Kabadayi, Gokhan
    Yildirim, Tolga
    Aysin, Idil Kurut
    Karadag, Omer
    Akar, Servet
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) : 675 - 676
  • [8] Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis
    Walsh, Michael
    Flossman, Oliver
    Berden, Annelies
    Westman, Kerstin
    Manns, Braden
    Jayne, David
    APMIS, 2009, 117 : 140 - 140
  • [9] THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS
    Walsh, Michael
    Merkel, Peter
    Jayne, David
    RHEUMATOLOGY, 2019, 58
  • [10] The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death
    Walsh, Michael
    Flossman, Oliver
    Berden, Annelies
    Westman, Kerstin
    Manns, Braden
    Jayne, David
    APMIS, 2009, 117 : 143 - 144
12345